Medical device tax: Group purchasers call out 45 “cost-shifting” medtech companies coverage of the medical device tax

Medical device makers Allergan (NYSE:AGN) and Invacare (NYSE:IVC) are among the companies targeted by the Healthcare Supply Chain Assn. for allegedly shifting the cost of a new federal excise tax to their customers.

A new website sponsired by the organization is the latest effort in an ongoing battle between group purchasers and medical device makers over the 2.3% medical device tax that took effect at the start of the year.

Several surveys have shown that many companies plan to raise prices in order to cover the impact of the sales levy, but healthcare purchasing groups have pushed back, accusing some device makers of dodging their obligation to contribute to the cost of healthcare reform.

Allergan and Invacare did not immediately return requests for comment.

Allergan has been quiet about its plans for dealing with the tax, but Invacare has made no secret of its intentions to pass the tax onto customers.

"Based on its interpretation of the regulations, the company expects that the impact from the tax when it first takes effect in 2013 will be less than $1.5 million; and it intends to pass it on to the market," Invacare said in a press release issued late last year.

Medical device makers have been actively fighting for repeal of the tax, but buyers like the Healthcare Supply Chain Assn. have stayed out of the debate over whether the levy itself is appropriate or not.

"HSCA took no position on the medical device excise tax, other than expressing its concern that the device industry not be allowed to pass along the cost of the tax to hospitals – in effect, double-taxing hospitals," HSCA president Curtis Rooney said in prepared remarks posted on the "Medical Device Tax Watch" website. "It is disheartening to find that some medical device companies have chosen to tack the tax right onto their invoices."

Purchasing groups have gone so far as to petition the IRS to protect hospitals from price hikes by requiring device makers to promise that their tax burden isn’t baked into their prices.

The effort is not in vain, as a handful of industry surveys have already found that medical device companies are looking for various ways to offset the cost of the medical device tax, including by raising prices for their products. A GPO protest, however, packs quite a punch. About 96%-98% of hospitals use some form of group purchasing and ¾ of hospital purchases are made through GPOs, according to HSCA.

"American hospitals have already lived up to their shared financial responsibility for national healthcare reform, and now face mounting budgetary strain as they continue to deliver affordable and effective patient care with fewer dollars," according to Rooney.  "As hospitals, long-term care facilities and other healthcare providers continue to stretch their budget dollars, they will continue to rely on their GPO partners to reduce healthcare costs and deliver the best medical products and services at the best value."

HSCA, formerly the Health Industry Group Purchasing Assn., represents 15 group purchasing organizations with a mission of advocacy, education, sales and utilization of goods and services within the health industry. Medtech buying titans Premier health alliance and Novation are both member organizations.

Last month group purchasing organization Novation issued a "firm stance" of its own, accusing unnamed device makers of shifting their tax burdens onto an already stressed healthcare system.

The HSCA’s full list of "cost-shifting suppliers" includes:

  • Acuderm
  • Alere
  • Allergan
  • AMX Solutions
  • Anatech Ltd
  • Applied Medical Technology
  • Arthrosurface
  • Beekley Medical
  • Berkeley Advanced Biomaterials
  • Burlington Medical Supplies, Inc.
  • CIRS (Computerized Imaging Reference Systems)
  • Cardica
  • Cerner
  • Encompas
  • EMD Millipore
  • FHC
  • Fine Surgical Instruments
  • Fujirebio
  • General Devices
  • Good Lite
  • Gynex
  • Hans Rudolph
  • Hurricane Medical
  • I.C. Medical , Inc.
  • Integra Life Sciences
  • Inrad, Inc.
  • Invacare
  • Iridix
  • Mastel
  • Misonix
  • New World Medical
  • Ohio Medical
  • Rycor Medical
  • Scanlan
  • Sientra
  • Skeletal Dynamics
  • Spineview
  • Staar Surgical
  • Stradis Healthcare
  • Technical Prospects
  • Tenacore
  • Thompson Surgical Instruments
  • Tosoh Bioscience
  • Unipower
  • Vacumetrics
  • Waters Corp

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply